• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

JAK/STAT 信号通路及其下游影响因素在动脉粥样硬化治疗中的作用。

The Role of JAK/STAT Signaling Pathway and Its Downstream Influencing Factors in the Treatment of Atherosclerosis.

机构信息

The First Clinical Medical College of Shandong University of Traditional Chinese Medicine, Jinan City, Shandong Province, China.

Hospital of Shandong University of Traditional Chinese Medicine, Jinan City, Shandong Province, China.

出版信息

J Cardiovasc Pharmacol Ther. 2024 Jan-Dec;29:10742484241248046. doi: 10.1177/10742484241248046.

DOI:10.1177/10742484241248046
PMID:38656132
Abstract

Atherosclerosis is now widely considered to be a chronic inflammatory disease, with increasing evidence suggesting that lipid alone is not the main factor contributing to its development. Rather, atherosclerotic plaques contain a significant amount of inflammatory cells, characterized by the accumulation of monocytes and lymphocytes on the vessel wall. This suggests that inflammation may play a crucial role in the occurrence and progression of atherosclerosis. As research deepens, other pathological factors have also been found to influence the development of the disease. The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway is a recently discovered target of inflammation that has gained attention in recent years. Numerous studies have provided evidence for the causal role of this pathway in atherosclerosis, and its downstream signaling factors play a significant role in this process. This brief review aims to explore the crucial role of the JAK/STAT pathway and its representative downstream signaling factors in the development of atherosclerosis. It provides a new theoretical basis for clinically affecting the development of atherosclerosis by interfering with the JAK/STAT signaling pathway.

摘要

动脉粥样硬化现在被广泛认为是一种慢性炎症性疾病,越来越多的证据表明,脂质本身并不是导致其发展的主要因素。相反,粥样硬化斑块含有大量的炎症细胞,其特征是单核细胞和淋巴细胞在血管壁上的积累。这表明炎症可能在动脉粥样硬化的发生和发展中起关键作用。随着研究的深入,其他病理因素也被发现会影响疾病的发展。Janus 激酶/信号转导和转录激活因子(JAK/STAT)途径是最近发现的炎症靶点,近年来受到关注。许多研究为该途径在动脉粥样硬化中的因果作用提供了证据,其下游信号因子在这一过程中起着重要作用。本综述旨在探讨 JAK/STAT 途径及其代表性下游信号因子在动脉粥样硬化发展中的关键作用,为临床上通过干扰 JAK/STAT 信号通路来影响动脉粥样硬化的发展提供新的理论依据。

相似文献

1
The Role of JAK/STAT Signaling Pathway and Its Downstream Influencing Factors in the Treatment of Atherosclerosis.JAK/STAT 信号通路及其下游影响因素在动脉粥样硬化治疗中的作用。
J Cardiovasc Pharmacol Ther. 2024 Jan-Dec;29:10742484241248046. doi: 10.1177/10742484241248046.
2
Targeting JAK/STAT signaling pathways in treatment of inflammatory bowel disease.靶向 JAK/STAT 信号通路治疗炎症性肠病。
Inflamm Res. 2021 Jul;70(7):753-764. doi: 10.1007/s00011-021-01482-x. Epub 2021 Jul 1.
3
Sometimes Small Is Beautiful: Discovery of the Janus Kinases (JAK) and Signal Transducer and Activator of Transcription (STAT) Pathways and the Initial Development of JAK Inhibitors for IBD Treatment.有时小即是美:Janus激酶(JAK)和信号转导及转录激活因子(STAT)通路的发现以及用于炎症性肠病治疗的JAK抑制剂的初步研发
Dig Dis Sci. 2025 Mar;70(3):890-898. doi: 10.1007/s10620-024-08791-1. Epub 2025 Jan 18.
4
Therapeutic inhibition of the JAK-STAT pathway in the treatment of inflammatory bowel disease.JAK-STAT 通路的治疗性抑制在炎症性肠病治疗中的作用。
Cytokine Growth Factor Rev. 2024 Oct;79:1-15. doi: 10.1016/j.cytogfr.2024.07.008. Epub 2024 Aug 3.
5
JAK/STAT of all trades: linking inflammation with cancer development, tumor progression and therapy resistance.JAK/STAT 多面手:将炎症与癌症发生、肿瘤进展和治疗抵抗联系起来。
Carcinogenesis. 2021 Dec 31;42(12):1411-1419. doi: 10.1093/carcin/bgab075.
6
Medicinal chemistry perspective of JAK inhibitors: synthesis, biological profile, selectivity, and structure activity relationship.JAK抑制剂的药物化学视角:合成、生物学特性、选择性及构效关系
Mol Divers. 2024 Dec;28(6):4467-4513. doi: 10.1007/s11030-023-10794-5. Epub 2024 Jan 18.
7
Phytochemicals Targeting JAK-STAT Pathways in Inflammatory Bowel Disease: Insights from Animal Models.植物化学物质靶向 JAK-STAT 通路治疗炎症性肠病:来自动物模型的研究进展。
Molecules. 2021 May 10;26(9):2824. doi: 10.3390/molecules26092824.
8
JAK-STAT Pathway Inhibition and their Implications in COVID-19 Therapy.JAK-STAT 通路抑制及其在 COVID-19 治疗中的意义。
Postgrad Med. 2021 Jun;133(5):489-507. doi: 10.1080/00325481.2020.1855921. Epub 2020 Dec 16.
9
Janus kinase inhibitors in dermatology: Part I. A comprehensive review.皮肤科中的 Janus 激酶抑制剂:第一部分。全面综述。
J Am Acad Dermatol. 2022 Feb;86(2):406-413. doi: 10.1016/j.jaad.2021.07.002. Epub 2021 Jul 8.
10
The rationale for targeting the JAK/STAT pathway in scleroderma-associated interstitial lung disease.针对硬皮病相关间质性肺病中 JAK/STAT 通路的作用机制。
Immunotherapy. 2021 Feb;13(3):241-256. doi: 10.2217/imt-2020-0270. Epub 2020 Dec 2.

引用本文的文献

1
Effects of treatment with janus kinase inhibitors on coronary microvascular perfusion in patients with rheumatoid arthritis: an observational prospective cohort study.Janus激酶抑制剂治疗对类风湿关节炎患者冠状动脉微血管灌注的影响:一项观察性前瞻性队列研究。
Rheumatol Int. 2025 Apr 19;45(5):111. doi: 10.1007/s00296-025-05862-y.
2
Mechanism Exploration of Dunyeguanxinning in the Treatment of Atherosclerosis Based on UPLC-Q-Orbitrap HRMS Technology, Network Pharmacology, Molecular Docking and Experimental Validation.基于超高效液相色谱-四极杆-轨道阱高分辨质谱技术、网络药理学、分子对接及实验验证的敦液冠心宁治疗动脉粥样硬化的机制探索
J Inflamm Res. 2025 Apr 9;18:4857-4878. doi: 10.2147/JIR.S511604. eCollection 2025.
3
Polyinosinic-polycytidylic acid modulates -induced cell apoptosis via the janus kinase/ signal transducer and activator of transcription signaling pathway.
聚肌苷酸-聚胞苷酸通过 Janus 激酶/信号转导及转录激活因子信号通路调节诱导的细胞凋亡。
J Dent Sci. 2025 Apr;20(2):811-818. doi: 10.1016/j.jds.2024.09.021. Epub 2024 Oct 11.
4
STAT3 Signaling Pathway in Health and Disease.健康与疾病中的信号转导和转录激活因子3(STAT3)信号通路
MedComm (2020). 2025 Mar 30;6(4):e70152. doi: 10.1002/mco2.70152. eCollection 2025 Apr.
5
MiR-203 improved renal cell injury in diabetic nephropathy by targeting SOCS6/SOCS7 and inhibiting JAK/STAT pathway activation.微小RNA-203通过靶向细胞因子信号转导抑制因子6/细胞因子信号转导抑制因子7并抑制JAK/STAT信号通路激活来改善糖尿病肾病中的肾细胞损伤。
Sci Rep. 2025 Mar 28;15(1):10684. doi: 10.1038/s41598-025-95952-5.
6
Investigating the Potential Therapeutic Targeting of the JAK-STAT Pathway in Cerebrovascular Diseases: Opportunities and Challenges.研究JAK-STAT通路在脑血管疾病中的潜在治疗靶点:机遇与挑战
Mol Neurobiol. 2025 Mar 18. doi: 10.1007/s12035-025-04834-4.
7
Inflammatory Pathways in Coronary Artery Disease: Which Ones to Target for Secondary Prevention?冠状动脉疾病中的炎症通路:二级预防应针对哪些通路?
Cells. 2025 Jan 21;14(3):153. doi: 10.3390/cells14030153.
8
Immunological perspectives on atherosclerotic plaque formation and progression.免疫视角下的动脉粥样硬化斑块形成与进展。
Front Immunol. 2024 Sep 27;15:1437821. doi: 10.3389/fimmu.2024.1437821. eCollection 2024.